Oncolys BioPharma
4588.TTSE GROWTHPharmaceutical
Financials · Consolidated
No consolidated annual figures structured yet.
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 18
| Period | Form | Figures |
|---|---|---|
| 2026-01-01 → 2026-06-30 | Half-year | 66 figures · EDINET |
| 2025-01-01 → 2025-12-31 | Annual | 107 figures · EDINET |
| 2025-01-01 → 2025-06-30 | Half-year | 66 figures · EDINET |
| 2024-01-01 → 2024-12-31 | Annual | 107 figures · EDINET |
| 2024-01-01 → 2024-06-30 | Half-year | 66 figures · EDINET |
| 2024-01-01 → 2024-03-31 | Quarterly Q1 | 40 figures · EDINET |
| 2023-01-01 → 2023-12-31 | Annual | 107 figures · EDINET |
| 2023-01-01 → 2023-09-30 | Quarterly Q3 | 44 figures · EDINET |
| 2023-01-01 → 2023-06-30 | Quarterly Q2 | 68 figures · EDINET |
| 2023-01-01 → 2023-03-31 | Quarterly Q1 | 42 figures · EDINET |
| 2022-01-01 → 2022-12-31 | Annual | 107 figures · EDINET |
| 2020-01-01 → 2020-12-31 | AnnualAmended | 114 figures · EDINET |
| 2021-01-01 → 2021-12-31 | AnnualAmended | 107 figures · EDINET |
| 2019-01-01 → 2019-12-31 | AnnualAmended | 113 figures · EDINET |
| 2017-01-01 → 2017-12-31 | AnnualAmended | 110 figures · EDINET |
| 2018-01-01 → 2018-12-31 | AnnualAmended | 110 figures · EDINET |
| 2022-01-01 → 2022-09-30 | Quarterly Q3 | 44 figures · EDINET |
| 2022-01-01 → 2022-06-30 | Quarterly Q2 | 68 figures · EDINET |
29 more reports are still being processed.